Should a platelet limit of 600 x 109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 15-23

  Lengfelder, Eva ^a   Hochhaus, Andreas ^a   Kronawitter, Ursula ^b   Höche, Dietrich ^c   Queisser, Wolfgang ^a   Jahn Eder, Michaela ^b   Burkhardt, Rolf ^b   Reiter, Andreas ^a   Ansari, Hassan ^d   Hehlmann, Rüdiger ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bone marrow histology; Diagnostic criteria; Early essential thrombocythaemia; Myeloproliferative disorder; Prognostic factors

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; ALPHA INTERFERON; BUSULFAN; HYDROXYUREA;

ADULT; AGED; ARTICLE; BLEEDING; BONE MARROW BIOPSY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOEMBOLISM; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; AGED; BONE MARROW DISEASES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 6844261163     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00529.x     Document Type: Article

References (28)

1. Alpert, J.S. & Dalen, J.E. (1994) Epidemiology and natural history of venous thromboembolism. Progress in Cardiovascular Diseases, 36, 417-422.
2. Barbui, T., Finazzi, G., Dupuy, E., Kiladjian, J.J. & Briere, J. (1996) Treatment strategies in essential thrombocythemia: a critical appraisal of various experiences in different centers. Leukemia and Lymphoma, 22, (Suppl. 1). 143-148.
3. Baumann, B., Hillmar, I. & Hehlmann, R. (1988) Untersuchungen zur Thrombozytenfunktion bei essentieller Thrombozythämie und reaktiver Thrombozytose. Klinische Wochenschrift, 66, 199-207.
4. Burkhardt, R. (1988) Bone marrow in megakaryocytic disorders. Hematology/Oncology Clinics of North America, 2, 695-733.
5. Burkhardt, R., Bartl, R., Jäger, K., Frisch, B., Kettner, G., Mahl, G. & Sund, M. (1984) Chronic myeloproliferative disorders (CMPD), Pathology, Research and Practice, 179, 131-186.
6. Burkhardt, R., Jaeger, K., Kettner, G. & Helmer, G. (1990) Chronic myeloproliferative disorders: prognostic importance of new working classification. Journal of Clinical Pathology, 43, 357-364.
7. Comings, D.E. (1978) Methods and mechanisms of chromosome banding. Methods in Cell Biology, 17, 115-132.
8. Cortelazzo, S., Finazzi, G., Ruggeri, M., Vestri, O., Alli, M., Rodeghiero, F. & Barbui, T. (1995) Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. New England Journal of Medicine, 332, 1132-1136.
9. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society, 34, 187-220.
10. Frank, K., Linhard, P., Kortsik, C., Wohlenberg, H. (1986) Sonographische Milzgrössenbestimmung: Normalmasse beim milzgesunden Erwachsenen. Ultraschall, 7, 134-137.
11. Georgii, A., Vykoupil, K.F., Buhr, T., Choritz, H., Döhler, U., Kaloutsi, V., Werner, M. (1990) Chronic myeloproliferative disorders in bone marrow biopsies. Pathology, Research and Practice, 186, 3-27.
12. Hehlmann, R., Jahn, M., Baumann, B. & Köpcke, W. (1988) Essential thrombocythemia: clinical characteristics and course of 61 cases. Cancer, 61, 2487-2496.
13. Hochhaus, A., Höche, D., Mindner, K., Ostermann, G. & Meyer, M. (1989) Die megakaryozytäre Myelose: Klinik, Morphologie und Plättchenfunktion. Klinische Wochenschrift, 68, 51-59.
14. Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
15. Kutti, J. & Wadenvick, H. (1996) Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis. Leukemia and Lymphoma, 22, (Suppl. 1), 41-54.
16. Löwel, H., Lewis, M., Keil, U., König, W., Hörmann, A., Bolte, H.D. & Gostomzyk, J. (1988) Zur Herzinfarktsituation in einer süddeutschen Bevölkerung: Ergebnisse des Augsburger Herzinfarktregisters 1985. Zeitschrift für Kardiologie, 77, 481-489.
17. Mantel, N. (1966) Evaluation of survival data and two new rank or statistics arising in its consideration. Cancer Chemotherapy Reports, 50, 163-170.
18. Millard, F.E., Hunter, C.S., Anderson, M., Edelman, M.J., Kosty, M.P., Luiken, G.A. & Martino, G.G. (1990) Clinical manifestations of essential thrombocythemia in young adults. American Journal of Hematology, 33, 27-31.
19. Mitus, A.J., Barbui, T., Shulman, L.N., Rosenthal, D.S., Viero, P., Cortelazzo, S. & Schafer, A.I. (1990) Hemostatic complications in young patients with essential thrombocythemia. American Journal of Medicine, 88, 371-375.
20. Murphy, S., Illand, H., Rosenthal, D. & Laszlo, J. (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Seminars in Hematology, 23, 177-182.
21. Murphy, S., Peterson, P., Iland, H. & Lazlo, J. (1997) Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Seminars in Hematology, 34, 29-39.
22. Randi, M.L., Fabris, F. & Girolami, A. (1990) Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40. Blut, 60, 233-237.
23. Reiter, A., Skladny, H., Hochhaus, A., Seifarth, W., Heimpel, H., Bartram, C.R., Cross, N.C.P., Hehlmann, R., and the German CML Study Group (1997) Molecular response of CML patients treated with interferon alpha monitored by quantitative Southern blot analysis. British Journal of Haematology, 97, 86-93.
24. Rozman, C., Giralt, M., Feliu, E., Rubio, D. & Cortes, M.T. (1990) Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer, 67, 2658-2663.
25. Thiele, J., Kvasnicka, K.M., Werden, C., Zankovich, R., Diehl, V., Fischer, R. (1996) Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leukemia and Lymphoma, 22, 303-317.
26. Thiele, J., Schneider, G., Hoeppner, B., Wienhold, S., Zankovich, R. & Fischer, R. (1988) Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis - features of significance for the diagnosis of primary (essential) thrombocythaemia. Virchows Archiv A: Pathological Anatomy and Histopathology, 413, 407-417.
27. Thiele, J., Zankovich, R., Steinberg, Th., Kremer, B., Fischer, R. & Diehl, V. (1989) Primary (essential) thrombocythaemia versus initial (hyperplastic) stages of agnogenic myeloid metaplasia with thrombocylosis: a critical evaluation of clinical and histomorphologic data. Acta Haematologica, 81, 192-202.
28. Vadher, B.D., Machin, S.J., Patterson, K.G., Sukhu, C. & Walker, H. (1993) Life-threatening thrombotic and haemorrhagic problems associated with silent myeloproliferative disorders. British Journal of Haematology, 85, 213-216.